Atomistry » Zinc » PDB 4i7b-4ign » 4i9z
Atomistry »
  Zinc »
    PDB 4i7b-4ign »
      4i9z »

Zinc in PDB 4i9z: Crystal Structure of the PDE5A1 Catalytic Domain in Complex with Novel Inhibitors

Enzymatic activity of Crystal Structure of the PDE5A1 Catalytic Domain in Complex with Novel Inhibitors

All present enzymatic activity of Crystal Structure of the PDE5A1 Catalytic Domain in Complex with Novel Inhibitors:
3.1.4.35;

Protein crystallography data

The structure of Crystal Structure of the PDE5A1 Catalytic Domain in Complex with Novel Inhibitors, PDB code: 4i9z was solved by J.Ren, T.Chen, Y.Xu, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 46.30 / 2.08
Space group P 31 2 1
Cell size a, b, c (Å), α, β, γ (°) 74.850, 74.850, 132.280, 90.00, 90.00, 120.00
R / Rfree (%) 20.1 / 23.7

Other elements in 4i9z:

The structure of Crystal Structure of the PDE5A1 Catalytic Domain in Complex with Novel Inhibitors also contains other interesting chemical elements:

Bromine (Br) 1 atom
Magnesium (Mg) 1 atom

Zinc Binding Sites:

The binding sites of Zinc atom in the Crystal Structure of the PDE5A1 Catalytic Domain in Complex with Novel Inhibitors (pdb code 4i9z). This binding sites where shown within 5.0 Angstroms radius around Zinc atom.
In total only one binding site of Zinc was determined in the Crystal Structure of the PDE5A1 Catalytic Domain in Complex with Novel Inhibitors, PDB code: 4i9z:

Zinc binding site 1 out of 1 in 4i9z

Go back to Zinc Binding Sites List in 4i9z
Zinc binding site 1 out of 1 in the Crystal Structure of the PDE5A1 Catalytic Domain in Complex with Novel Inhibitors


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 1 of Crystal Structure of the PDE5A1 Catalytic Domain in Complex with Novel Inhibitors within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Zn902

b:31.2
occ:1.00
OD1 A:ASP654 2.1 18.8 1.0
NE2 A:HIS617 2.2 17.2 1.0
NE2 A:HIS653 2.2 16.2 1.0
O A:HOH1004 2.2 21.2 1.0
OD2 A:ASP764 2.3 19.4 1.0
O A:HOH1138 2.4 19.9 1.0
CD2 A:HIS617 3.1 17.1 1.0
CD2 A:HIS653 3.1 18.0 1.0
CG A:ASP654 3.1 20.4 1.0
CG A:ASP764 3.2 24.5 1.0
CE1 A:HIS617 3.2 18.9 1.0
CE1 A:HIS653 3.3 17.4 1.0
OD1 A:ASP764 3.5 26.8 1.0
OD2 A:ASP654 3.7 19.6 1.0
MG A:MG903 3.9 26.2 1.0
O A:HOH1055 4.0 27.7 1.0
O A:HOH1137 4.0 19.9 1.0
CD2 A:HIS613 4.1 22.4 1.0
NE2 A:HIS613 4.3 22.8 1.0
CG A:HIS617 4.3 17.4 1.0
CG A:HIS653 4.3 20.4 1.0
ND1 A:HIS617 4.3 17.7 1.0
ND1 A:HIS653 4.3 15.1 1.0
CB A:ASP654 4.3 19.3 1.0
CB A:ASP764 4.6 19.4 1.0
O A:ASP764 4.7 17.5 1.0
O A:HOH1002 4.8 22.8 1.0
OG1 A:THR621 4.9 15.0 1.0
CA A:ASP764 4.9 17.1 1.0

Reference:

X.Gong, G.Wang, J.Ren, Z.Liu, Z.Wang, T.Chen, X.Yang, X.Jiang, J.Shen, H.Jiang, H.A.Aisa, Y.Xu, J.Li. Exploration of the 5-Bromopyrimidin-4(3H)-Ones As Potent Inhibitors of PDE5. Bioorg.Med.Chem.Lett. V. 23 4944 2013.
ISSN: ISSN 0960-894X
PubMed: 23867165
DOI: 10.1016/J.BMCL.2013.06.062
Page generated: Wed Dec 16 05:23:30 2020

Last articles

Zn in 7RE3
Zn in 7RDX
Zn in 7RDZ
Zn in 7RWM
Zn in 7PGU
Zn in 7PGR
Zn in 7PGT
Zn in 7PGS
Zn in 7SQE
Zn in 7RWK
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy